Psychological Status and Quality of Life Associated with Radioactive Iodine Treatment of Patients with Differentiated Thyroid Cancer: Results of Hospital Anxiety and Depression Scale and Short-Form (36) Health Survey.
Differentiated thyroid cancer
Hospital Anxiety and Depression Scale
psychological status
quality of life
radioactive iodine
short-form (36) health survey
Journal
Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
ISSN: 0972-3919
Titre abrégé: Indian J Nucl Med
Pays: India
ID NLM: 8901274
Informations de publication
Date de publication:
Historique:
received:
25
01
2020
revised:
18
02
2020
accepted:
04
03
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
22
10
2020
Statut:
ppublish
Résumé
The objective is to investigate psychological status and quality of life (QoL) using Hospital Anxiety and Depression Scale (HADS) and Short-Form (36) Health Survey (SF-36) questionnaires in patients with proven differentiated thyroid cancer (DTC) who are referred for radioactive iodine (RAI) ablation before, during, and after treatment. Of patients who underwent total thyroidectomy with a pathologically proven DTC (papillary and follicular types) referred for RAI treatment to our department in 2018, 150, in whom the diagnosis was newly established, were referred for the first course of RAI treatment and were consecutively enrolled in the study. The patients received an oral dose of radioiodine (3700 or 5550 MBq). For evaluation of anxiety, depression, and QoL, all patients are given two standard questionnaires, HADS, and SF-36 and are requested to answer them at four time points. First one was at 1 month before RAI, second was at the time of RAI treatment. Third and fourth ones were 1 week and 6 months later, respectively. The mean age of patients was 39.17 (±12.95) years and 121 (80.7%) were female and 29 (19.3%) were male. Values of HADS and SF-36 scores at corresponding time points were significantly correlated using Pearson correlation (HADS and SF-36 scores at 1 month before RAI: Trend in scores over several-months' time discloses gradual improvement of QoL and merits close observation but limited psychiatric intervention.
Identifiants
pubmed: 33082677
doi: 10.4103/ijnm.IJNM_14_20
pii: IJNM-35-216
pmc: PMC7537913
doi:
Types de publication
Journal Article
Langues
eng
Pagination
216-221Informations de copyright
Copyright: © 2020 Indian Journal of Nuclear Medicine.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Natl Cancer Inst. 2018 Dec 1;110(12):1300-1310
pubmed: 30496448
Bol Asoc Med P R. 2015 Jan-Mar;107(1):25-31
pubmed: 26035981
Thyroid. 2013 Oct;23(10):1247-55
pubmed: 23578315
Neuropsychiatr Dis Treat. 2016 May 02;12:1055-60
pubmed: 27194911
Qual Life Res. 1993 Dec;2(6):369-95
pubmed: 8161975
Thyroid. 2015 Dec;25(12):1313-21
pubmed: 26431811
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
JAMA. 2017 Apr 4;317(13):1338-1348
pubmed: 28362912
Ann Endocrinol (Paris). 2010 Mar;71(2):95-101
pubmed: 20036351
Eur Thyroid J. 2013 Sep;2(3):195-202
pubmed: 24847453
Thyroid. 1997 Aug;7(4):613-9
pubmed: 9292951
J Clin Endocrinol Metab. 2008 Jan;93(1):200-3
pubmed: 17956954
J Insur Med. 2018 Jan;47(3):143-158
pubmed: 30192723
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1179-88
pubmed: 25771905
Health Soc Work. 1996 Aug;21(3):230-4
pubmed: 8854128
Ann Endocrinol (Paris). 2019 Feb;80(1):26-31
pubmed: 29571888
Qual Life Res. 2005 Apr;14(3):875-82
pubmed: 16022079